SIGMA Healthcare has upgraded its full year normalised EBIT guidance for the year ending 31 Jan 2025 to $64-$70 million, up from the $50-$60 million range previously guided in Sep 2024.
The new Chemist Warehouse supply contract has been largely to thank for the improved operational performance, Sigma said.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Feb 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Feb 25
